-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Market Perform on Arrowhead Pharma, Raises Price Target to $46

Benzinga·05/13/2026 18:33:01
Listen to the news
Bernstein analyst William Pickering maintains Arrowhead Pharma (NASDAQ:ARWR) with a Market Perform and raises the price target from $35 to $46.